BSE · 526504
Dolphin Medical Services Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1 Cr with net profit ₹-0 Cr — a -6.46% net margin, versus -152.24% the period before.
Shareholding
As of 2026-09-30
- Promoter100%
41 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 4.81× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Healthcare · ranked #59 of 86 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,17,903 Cr | 56.04 | 12.43 | 20.48% | 7.91% |
| Manipal Health Enterpri Limited | ₹84,026 Cr | 89.59 | 5.12 | 10.59% | 7.81% |
| Max Healthcare Institute Ltd. | ₹82,843 Cr | 55.34 | 7.71 | 13.42% | 16.73% |
| Aster DM Quality Care Ltd. | ₹59,182 Cr | 152.57 | 14.07 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹56,992 Cr | 53.43 | 5.75 | 10.53% | 11.02% |
| Narayana Hrudayalaya Ltd. | ₹35,038 Cr | 40.65 | 7.72 | 17.76% | 9% |
| Global Health Limited | ₹34,946 Cr | 61.05 | 8.82 | 14.05% | 11.88% |
| Dr. Lal Path Labs Ltd. | ₹32,088 Cr | 57.05 | 12.8 | 20.13% | 18.75% |
| Krishna Institute of Medical Sciences Ltd. | ₹29,505 Cr | 141.35 | 7.87 | 10.74% | 4.85% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 105.1 | 7.65 | 6.58% | 6.72% |
| Dolphin Medical Services Ltd.(this company) | ₹10 Cr | 226 | 1.02 | 0.61% | 7.59% |
AI analysis
AI-generated · google/gemini-2.5-flashDolphin Medical Services Ltd. has a market capitalization of Rs 12 Cr. The company's EPS stands at 0.03, and it has a book value per share of Rs 6.68. The current P/E ratio is 262.33.
Positives
- +The Return on Equity (ROE) is 41.56% which suggests efficient use of shareholder funds.
- +Promoter shareholding has no pledges (0%).
- +The profit margin of 9.33% indicates some level of profitability in its operations.
Negatives
- −The trailing twelve months P/E ratio is substantially high at 262.33.
- −The Return on Capital Employed (ROCE) is low at 0.6467%.
- −The company's promoter holding of 26.4392% is low.
- −The company has been placed under the Graded Surveillance Measure (GSM).
Financial Performance
In the quarter ending Mar 2026, Dolphin Medical Services Ltd. reported revenue of Rs 0.19 Cr and a net profit of Rs 0.01 Cr. This follows a revenue of Rs 0.21 Cr and a net profit of Rs 0.02 Cr in the Dec 2025 quarter. The company experienced negative EBITDA of -0.06 in the Mar 2025 quarter, with revenue of Rs 0.14 Cr and a net loss of -0.07 Cr during that period.
Profitability & Returns
Dolphin Medical Services Ltd. reported a profit margin of 9.33%. The Return on Equity (ROE) is 41.56%, while the Return on Capital Employed (ROCE) is 0.6467%.
Balance Sheet
The company's debt-to-equity ratio is 0.63. The book value per share is Rs 6.68.
Ownership & Pledges
The total number of shareholders is 10111.
Regulatory & Surveillance
Dolphin Medical Services Ltd. is currently under surveillance with a 'GSM 0' label, indicating it is subject to the Graded Surveillance Measure (GSM) by regulatory authorities.
Data as of — price: 2026-10-30 · financials: Mar 16 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Dolphin Medical Services Ltd.share price & fundamentals